Why the study?
What clinical features distinguish cardiac sarcoidosis from arrhythmogenic right ventricular dysplasia/cardiomyopathy in patients meeting ARVD/C diagnostic criteria?
What clinical features distinguish cardiac sarcoidosis from arrhythmogenic right ventricular dysplasia/cardiomyopathy in patients meeting ARVD/C diagnostic criteria?
Older age of symptom onset, PR prolongation, high-grade AV block, significant LV dysfunction, septal delayed enhancement, and mediastinal lymphadenopathy can help distinguish cardiac sarcoidosis from ARVD/C in patients meeting ARVD/C criteria.
May aid CS evaluation in ARVD/C mimics; hypothesis-generating and requires prospective validation.
BACKGROUND: Cardiac sarcoidosis (CS) may show overlap in the clinical presentation with arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). We sought to investigate patients with CS who were misdiagnosed with ARVD/C and identify clinical features to distinguish these 2 groups. METHODS AND RESULTS: Among patients enrolled in the Johns Hopkins ARVD/C registry, 15 patients with definite 2010 diagnostic criteria for ARVD/C were subsequently diagnosed with CS. Forty-two pathogenic desmosomal mutation carriers with definite ARVD/C based on the 2010 diagnostic criteria served as a control group. Patients with CS were older at the age of symptom onset, more likely to have comorbidities, and develop heart failure symptoms over time (P<0.05). Electrocardiographically, PR interval prolongation and high-grade atrioventricular block were exclusively associated with CS (P<0.05). HV interval prolongation and increased number of ventricular tachycardias induced were also associated with CS (P<0.05). Radiographically, significant left ventricular dysfunction, myocardial delayed enhancement of the septum, and mediastinal lymphadenopathy were more often see in those with CS (P<0.05). CONCLUSIONS: The 2010 diagnostic criteria for ARVD/C have limited discrimination in distinguishing between ARVD/C and CS. Despite the overlay in clinical presentation, older age of symptom onset, presence of cardiovascular comorbidities, nonfamilial pattern of disease, PR interval prolongation, high-grade atrioventricular block, significant left ventricular dysfunction, myocardial delayed enhancement of the septum, and mediastinal lymphadenopathy should raise the suspicion for CS.
No takes yet. Share an insight, caveat, or question.
Philips et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: